In a move that could significantly weaken global health security, the United States has officially concluded its withdrawal from the World Health Organization (WHO), marking the end of a 78-year partnership. This development follows President Trump's initial announcement one year prior, on his first day of his second term, signaling a decisive break from an organization that plays a crucial role in coordinating international responses to health emergencies. But here's where the controversy begins: despite the formal withdrawal, the process is far from clean or straightforward.
One of the key issues is the substantial debt the U.S. still owes to the WHO—over $130 million, to be precise. Many experts and officials acknowledge that some matters remain unresolved, such as the loss of access to vital data from other countries—information that is vital for early detection and warning of emerging pandemics within the U.S. and globally. Without this real-time intelligence, responses to new health threats could suffer delays, potentially costing countless lives.
Healthcare scholars and public health experts warn that this move will have severe consequences for international collaboration, especially in tackling outbreaks of diseases like Ebola, mpox (formerly monkeypox), or polio. Dr. Lawrence Gostin of Georgetown University describes the decision as potentially the most damaging presidential move he has witnessed, emphasizing that it undermines efforts to contain and prevent health crises worldwide.
The WHO, a specialized agency within the United Nations, has the vital mission of unifying efforts to manage and respond to health emergencies across the globe. It provides essential technical aid to poorer nations, helps distribute scarce vaccines and medicines, and establishes universally accepted guidelines for a myriad of health issues, from infectious diseases to mental health and cancer. Virtually every nation on Earth is a member of the WHO, reflecting its global importance.
Historically, the U.S. has been one of the organization's strongest supporters—both financially and technically—contributing hundreds of millions of dollars annually and providing expert personnel, especially through the Centers for Disease Control and Prevention (CDC). On average, the U.S. pays about $111 million annually in membership dues and approximately $570 million in voluntary contributions, according to the Department of Health and Human Services.
The withdrawal has profound, potentially devastating implications. As Dr. Judd Walson from Johns Hopkins University points out, over 750,000 excess deaths this year alone could be linked to these policy changes, predominantly affecting children in low- and middle-income countries. Without American funding and participation, WHO's capacity to monitor disease outbreaks, support supply chain logistics, and assist with health systems in vulnerable regions has been drastically diminished.
President Trump justified the withdrawal by criticizing WHO's handling of the COVID-19 pandemic and accusing it of failing to implement necessary reforms and demonstrating too much political influence from member states. He highlighted mistakes made during the pandemic, including initial guidance against mask-wearing and assertions that COVID-19 was not airborne—a stance retracted only by 2024.
Another point of contention has been the fact that none of WHO's nine chief executives since its inception have been American. U.S. officials have argued that this imbalance is unfair given the extent of American financial and human resources, notably the contributions from the CDC.
Critics warn that pulling out of the WHO could jeopardize ongoing programs such as the global effort to eradicate polio, maternal and child health initiatives, and viral threat research. Dr. Ronald Nahass of the Infectious Diseases Society of America criticizes the decision as shortsighted and scientifically irresponsible, emphasizing that international cooperation is an essential aspect of understanding and controlling infectious diseases.
Foreign policy experts like Tom Bollyky caution that the U.S. cannot insulate itself from transnational health threats. He points out the obvious irony: the best way to protect American citizens—and indeed, the global population—is to remain actively engaged with the international community, sharing data and resources.
By ceasing participation in WHO’s governance, technical committees, and disease monitoring groups, the U.S. is essentially withdrawing from critical global health infrastructure. For example, it is no longer involved in the vital flu strain monitoring committees that inform vaccine development, leaving the U.S. somewhat outside the loop of international disease intelligence. Despite claims by U.S. officials that they are establishing bilateral data-sharing agreements, experts question whether such arrangements will suffice, especially with countries like China or many African nations that may be hesitant or unwilling to share sensitive health data independently.
Furthermore, legal scholars argue that President Trump likely overstepped his authority by initiating this withdrawal, which, according to U.S. law, requires an act of Congress and a one-year notice period. The U.S. has yet to settle its financial obligations, owing over $133 million for the years 2024 and 2025, creating further complications.
As the world’s health landscape becomes increasingly interconnected, the question arises—can the U.S. truly afford to isolate itself from global health efforts? Or is this withdrawal a reckless gamble with future pandemics? What do you think—does staying engaged outweigh the risks? Share your thoughts and join the debate on this critical issue.
